GlaxoSmithKline Poaches AstraZeneca PLC Exec to Replace Exiting Pharma Head

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-glaxosmithkline.jpg" NAME"GlaxoSmithKline Poaches AstraZeneca PLC Exec to Replace Exiting Pharma Head" ALT"GlaxoSmithKline Poaches AstraZeneca PLC Exec to Replace Exiting Pharma Head"January 19, 2017By Mark Terry, BioSpace... Source: BioSpace

Continue ReadingGlaxoSmithKline Poaches AstraZeneca PLC Exec to Replace Exiting Pharma Head

<b>Martin Shkreli's</b> Complaint Leads to a $100 Million FTC Settlement for This Biotech

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-mallinckrot.jpg" NAME"Martin Shkreli's Complaint Leads to a $100 Million FTC Settlement for This Biotech" ALT"Martin Shkreli's Complaint Leads to a $100 Million FTC Settlement for This Biotech"January 19, 2017By…

Continue Reading<b>Martin Shkreli's</b> Complaint Leads to a $100 Million FTC Settlement for This Biotech

Not So Different After All: 5 Overlapping Skills Needed in Life Science Academia vs. Industry

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-overlapping-skills-academia-vs-industry.jpg" NAME"Not So Different After All: 5 Overlapping Skills Needed in Life Science Academia vs. Industry" ALT"Not So Different After All: 5 Overlapping Skills Needed in Life Science Academia…

Continue ReadingNot So Different After All: 5 Overlapping Skills Needed in Life Science Academia vs. Industry

What and His Potential Nominees Should Understand About the FDA

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"What Trump and His Potential Nominees Should Understand About the FDA" ALT"What Trump and His Potential Nominees Should Understand About the FDA"January 19, 2017By Mark Terry, BioSpace.com Breaking…

Continue ReadingWhat and His Potential Nominees Should Understand About the FDA